Ads
related to: Psoriatic Arthritis- Watch Video
Watch A Video To Learn More
About A Treatment For PsA.
- See Treatment Results
Help Relieve Your PsA Symptoms
With A Once-Daily Pill.
- PsA Treatment Options
Treatment Didn't Work?
See Additional Treatment Options.
- Try A Different Treatment
Still Experiencing PsA Symptoms?
A Change In Treatment Can Help.
- Find A Rheumatologist
Find A Rheumatologist Near You.
Set Goals For PsA Treatment.
- FDA-Approved PsA Pill
Not Meeting Your Treatment Goals?
Try Our Pill With Proven Results.
- Watch Video
Search results
Johnson & Johnson (NYSE:JNJ) Shares Purchased by Metis Global Partners LLC
ETF DAILY NEWS· 4 days agoMetis Global Partners LLC grew its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 17.6% in the 4th quarter, according to its most recent disclosure with the Securities and ...
Catalyst Financial Partners LLC Trims Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoCatalyst Financial Partners LLC reduced its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 11.6% in the 4th quarter, according to its most recent 13F filing with the Securities ...
Amgen (NASDAQ:AMGN) Shares Down 2.7% on Insider Selling
ETF DAILY NEWS· 7 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) shares were down 2.7% on Monday after an insider sold shares in the company. The company traded as low as $301.09 and last traded at $302.91. Specifically ...
Q2 2024 EPS Estimates for Amgen Inc. Reduced by Leerink Partnrs (NASDAQ:AMGN)
ETF DAILY NEWS· 7 days agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Stock analysts at Leerink Partnrs reduced their Q2 2024 earnings estimates for Amgen in a research report issued on Friday, May 3rd. Leerink Partnrs ...
Americans Got Drug-Resistant Infections After Stem Cell Treatments in Mexico
WFMZ Eastern Pennsylvania and Western New Jersey· 4 days agoKey Takeaways
ARS Wealth Advisors Group LLC Increases Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 days agoARS Wealth Advisors Group LLC raised its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 56.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The ...
MoonLake Immunotherapeutics Reports Q1 2024 Financial Outcomes
GuruFocus.com via Yahoo Finance· 6 days agoThe company's leading investigational product, sonelokimab, targets IL-17A and IL-17F, which are key drivers of inflammation in conditions such as hidradenitis suppurativa (HS) and ...
Nichols & Pratt Advisers LLP MA Has $80.12 Million Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoNichols & Pratt Advisers LLP MA cut its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 1.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & ...
Q3 2024 EPS Estimates for Johnson & Johnson (NYSE:JNJ) Cut by Analyst
ETF DAILY NEWS· 3 days agoJohnson & Johnson (NYSE:JNJ – Free Report) – Investment analysts at Zacks Research lowered their Q3 2024 earnings estimates for shares of Johnson & Johnson in a research note issued on Tuesday ...
Wealthspire Advisors LLC Has $14.28 Million Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoWealthspire Advisors LLC lifted its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 39.5% during the 4th quarter, according to the company in its most recent 13F filing with ...